『Viridian Executive Discusses FDA Approval of New TED Therapy』のカバーアート

Viridian Executive Discusses FDA Approval of New TED Therapy

Viridian Executive Discusses FDA Approval of New TED Therapy

無料で聴く

ポッドキャストの詳細を見る
An executive from Viridian discusses the FDA approval of Lumvoa for thyroid eye disease (TED); a biosimilar referencing Lucentis is relaunched in the US; and Lumibird introduces a wireless integrated laser-indirect-ophthalmoscope. Learn more about your ad choices. Visit megaphone.fm/adchoices
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません